Through this Two-page profile, we aim to allow the readers, including your prospective clients and business partners, to get a deeper understanding of mdi Consultants, Inc., on a more personal and extensive level.

The profile will cover the company’s various services and solutions, with an insight into how you are driving the organization to thwart market competition. The story will portray the strengths of the company and its unique value proposition to customers worldwide.

With that in mind, we have framed a few questions for which we are looking for your insightful responses.

Most Innovative Companies to Watch 2026

1. What inspired the creation of mdi Consultants, Inc., and what makes your approach unique in the regulatory industry?

Interesting question, “What inspired the creation of mdi”? After college there were two jobs available for a graduate with a degree in biology, working in the Museum of Natural History in the department of herpetology, or the FDA. The FDA looked more interesting so I took a position as an investigator in the NY District office. It’s funny, at that time, the FDA was not very well publicized and I didn’t have any idea what was the FDA’s function. Once I started the job, I said to myself, “the FDA regulated industry could use someone with FDA expertise”. I was always looking ahead on how to use my education to my advantage.  Starting as a GS-5 investigator for the FDA, I advanced through the ranks up to a GS-13 Supervisor and then had decided it was time for me to make a change. I had the option of moving to another district office, or to the Washington office of the FDA, or to work in the industry or start consulting. Looking back, out of all available options I thought I would like to try consulting. So I decided to set up a consulting company. This was right at the time, 1978, when the FDA was beginning to implement the new regulations pertaining the medical device industry. So, this was a new area of regulations and it helped me to generate consulting business. 

mdi was formed once I left the FDA in 1978.

2. How does the executive team contribute to the continued growth and innovation of mdi Consultants, Inc.?

I learned that to be successful you have to have a strong executive team starting with the office manager down to the bookkeeper along with the talented staff of experts to deal with a client company’s  regulatory issues. When we find a strong senior person, we hold on to them and build around them. That is what we did. We have a very strong nucleus of senior consultants with a group of staff consultants who have developed strong niche specialties while maintaining their overall FDA expertise. This gives our clients multiple views to outline a strong regulatory strategy to move forward.

3. How is the company driving innovation within the US regulatory landscape?

We learned that though the FDA does not change their regulations often (since it takes Congress to change the laws and regulations), the FDA does go about changing policies on a pretty regular basis. For example, as the FDA learns more about new technologies the companies approach the Agency with, FDA issues policies and guidance documents that represent their latest thinking. 

We try to keep up to date with the FDA’s thought process and are able to convey this to our clients providing them a regulatory pathway that makes sense.  Because of the volume of regulatory submissions that we handle and close interactions with FDA and other regulatory bodies, we can anticipate FDA reviewer questions and concerns before a new product application is even submitted. As a result, our clients know what to expect from the FDA review and how to navigate it. 

We also work closely with the FDA regulatory division and deal with providing required responses to the FDA warning letters.  We serve as a liaison between the audited company and the Agency and identify and help to implement mutually agreeable corrective actions to fully address the FDA’s concerns involving the company’ operations and compliance. 

You need to remember: The FDA does not change regulations too often but the FDA itself changes and they do update their policies.

4. What are some of the most significant milestones mdi Consultants, Inc. has achieved to date?

Over the past five decades, mdi Consultants became known in the industry and at the FDA as a trusted expert consulting company.  mdi journey reflects achievements of sustained growth, global influence, and unwavering commitment to regulatory excellence.  In our years in business, we have successfully guided over 500 companies through FDA, EU, and ISO compliance and thousands of various regulatory submissions resulting in marketing authorizations.  Our collective consulting experience is unmatched and is based on a global team with tenures of 20–45 years for senior members.  mdi is also a trusted U.S. Agent for multiple foreign manufacturers and combined with our direct experience of international cultures, we are able to assist these companies with a smooth U.S. market entry.

5. With 54 years of experience in FDA regulatory compliance to the medical device,

pharmaceutical, and food industries, mdi Consultants, Inc. has emerged as a leading provider of regulatory compliance consulting, FDA consulting for quality assurance, and other services to the healthcare industry. How the company is transforming the scenario of healthcare regulation in the USA?

mdi’s team is focused on recognizing emerging regulatory patterns by analysing the FDA reviewers interactions concerning various submissions and responses, and anticipating shifts long before formal guidance is released. This proactive approach reduces client risk, cost, and time-to-market.  

6. How does mdi Consultants, Inc., define impact for businesses?

With decades of experience, we learned to appreciate how overwhelming the regulatory journey can be for companies trying to bring new technologies to life or companies already in this highly regulated industry.  mdi’s mission is to become a trusted partner for our clients by making compliance understandable and achievable.  As part of this process, we anticipate the regulatory outcomes even before they occur so that we can guide the clients to their end goal in the most efficient and effective manner.  For our client companies seeking a new product approval, this means fast and accurate submissions with a quicker time to market and avoidance of costly redesigns and retests.  For companies in need of compliance remediation, our FDA-proven solutions mean ability to stay in business and move out of the FDA’s “bad list”.  

7. How does the company exemplify IT support with the help of technology?

mdi Consultants offers advanced penetration testing and ISO 27001–aligned guidance services in accordance with the FDA requirements for cybersecurity compliance. This helps companies address their digital devices’ potential vulnerabilities and strengthen operational risk response.

8. What’s next for mdi Consultants, Inc.?

mdi has always pride itself on staying ahead of emerging technologies. While the technologies change with time, our approach remained consistent. No matter the device, its indications for use and the mechanism of action, we work with our clients to assure their regulatory submissions can unequivocally prove the device’s safety and effectiveness.  With the digital health devices and AI-driven diagnostics becoming the main new players, mdi offers the device manufacturers the tools that can help them satisfy the new and evolving FDA regulations for digital health devices.  For example, we have partnered with an expert cybersecurity firm to help device manufacturers with the new FDA requirements for cybersecurity. 

P.S. As you have the complete editorial right, kindly let us know which format you want to publish, the QA format or the Story format. If it would be a story format then the word count will be confined to 1000 words.

We would like the QA format unless you feel that the story format would read better.